SX29 is an orally active non-competitive alpha-glucosidase inhibitor with an IC50 value of 2.12 µM. SX29 exhibits hypoglycemic activity, and oral administration of SX29 can reduce blood glucose levels and improve glucose tolerance in diabetic mice[1].
Molecular Weight:
518.59
Formula:
C30H22N4O3S
Target:
Glycosidase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
